Back to VANGUARD GROUP INC VANGUARD GROUP INC

CVKDCVKD
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in CADRENAL THERAPEUTICS INC

VANGUARD GROUP INC holds 53,912 shares of CVKD (CADRENAL THERAPEUTICS INC), worth $365,524 as of 2025-Q4. The position was decreased (-0.6% shares).

Current Value

$365,524

Current Shares

53,912

Total Value Change

-$438,986

Total Shares Change

+8,279

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
53,912
-0.6%
$365,5240.0%$6.62
0
2025-Q3
Increased
54,239
+11.6%
$747,1420.0%$13.42
19
2025-Q2
Increased
48,595
+6.5%
$585,5700.0%$10.44
18
2025-Q1
New
45,633
-
$804,5100.0%$18.46
38

Other major holders of CVKD: CITADEL ADVISORS LLC, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, LPL Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used